Bookmark

Add to MyYahoo RSS

Celgene News

News on Celgene (Ticker: CELG) continually updated from thousands of sources around the net.

Yesterday | Freshnews

Celgene Corporation to Present at Investor Conferences in September

Celgene Corporation announced that Celgene management will provide an overview of the Company at two upcoming investor conferences in the month of September.

Comment?

Related Topix: Biotech, Celgene, Medicine, Healthcare Industry, Investment Banking, Morgan Stanley European Fund, Financial Services, Morgan Stanley

Wed Aug 20, 2014

BioSpace

Bristol-Myers Squibb Company And Celgene Enter Clinical Collaboration ...

NEW YORK & SUMMIT, N.J.-- --Bristol-Myers Squibb Company and Celgene Corporation announced today the establishment of a clinical trial collaboration to evaluate the safety, tolerability and preliminary efficacy of a combination regimen of Bristol-Myers Squibb's investigational PD-1 immune checkpoint inhibitor, OPDIVO , and Celgene's nabA ... (more)

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Celgene, Summit, NJ, Bloomsbury Publishing, Publishing, Media, Medarex

Mon Aug 18, 2014

AmericanBankingNews.com

Celgene Hits New 1-Year High at $92.07

Celgene reached a new 52-week high during mid-day trading on Monday , Analyst Ratings Network.com reports.

Comment?

Related Topix: Biotech, Celgene, Medicine, Healthcare Industry

Investor's Business Daily

Jazz, Celgene Lead Top 4 Drugmaker Profit Margins

Its narcolepsy treatment, Xyrem, has rocketed to success and contributed to 65% of the drugmaker's 2013 revenue .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Celgene, Financial Markets

Seeking Alpha

Taking Profits From Netflix And Putting Them To Work In Celgene

At this point in the stock market I want to swap out of expensively valued stocks into at least fairly valued ones such as the swap I'm mentioning today.

Comment?

Related Topix: Netflix, Startups, Biotech, Celgene, Medicine, Healthcare Industry, Financial Markets

Thu Aug 14, 2014

Minyanville

Biotech Leads the Way

You will receive a download link right in your email inbox for each of the free reports that you choose.

Comment?

Related Topix: Startups, Pharmacyclics, Biotech, Celgene, Medicine, Healthcare Industry, Gilead Sciences

Tue Aug 12, 2014

BioSpace

5 Things Celgene Corporation's Management Wants You To Know

A little more than two weeks ago biotech giant Celgene delivered another smashing success of a quarter, at least along the lines of what the initial numbers entailed.

Comment?

Related Topix: Biotech, Celgene, Medicine, Healthcare Industry

Thu Aug 07, 2014

Seeking Alpha

2 Huge Immunology Opportunities For Celgene

Oral Otezla won't entirely displace injected biologics, but safety and convenience should easily push it over the $1 billion mark.

Comment?

Related Topix: Biotech, Celgene, Healthcare Industry, Psoriatic Arthritis, Health, Healthcare Law, Law

Wed Aug 06, 2014

Benzinga

Why Investors Should Closely Watch Celgene

The U.S. biotech firm Celgene Corp has filed as well, and its reported earnings beat Wall Street's expectations.

Comment?

Related Topix: Biotech, Celgene, Medicine, Healthcare Industry, Gilead Sciences

Tue Aug 05, 2014

AmericanBankingNews.com

Insider Selling: Perry A. Karsen Sells 39,104 Shares of Celgene Stock

Celgene Insider Perry A. Karsen sold 39,104 shares of the stock on the open market in a transaction dated Monday, August 4th.

Comment?

Related Topix: Biotech, Celgene, Medicine, Healthcare Industry

Seeking Alpha

Aspire Data A Big Plus For Amgen And Celgene

Strong interim data Yesterday, Amgen released data from a planned interim analysis of the Aspire study that could lead to a significant sales boost.

Comment?

Related Topix: Biotech, Medicine, Amgen, Healthcare Industry, Celgene, Startups, Onyx Pharmaceuticals, Johnson and Johnson

Thu Jul 31, 2014

Business Journal

Big biotech signals strategic move into Seattle; Is a buyout next?

Bob Hugin, chief executive officer of Celgene Corp., reported second-quarter results of $748 million in net income.

Comment?

Related Topix: Biotech, Celgene, Medicine, Healthcare Industry, VentiRx Pharmaceuticals, Oncology, Summit, NJ

Seeking Alpha

Celgene: Constantly Adding Signature Drugs To Its Healthy Portfolio

Future revenue growth: introducing Otezla in other markets and researching on four other indications that can be treated by Otezla in order to earn higher revenue from this drug.

Comment?

Related Topix: Biotech, Celgene, Healthcare Industry

Freshnews

The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.

Comment?

Related Topix: Biotech, Medicine, Science / Technology, Gilead Sciences, Healthcare Industry, Celgene, Financial Markets, Cancer, Health

TheStreet.com

Biotech Valuations Are Low Not Stretched. Here's Why.

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Mozilla, TheStreetcom, Media, TheStreet, Computers, Financial Markets

TheStreet.com

Biotech Valuations Are Low Not Stretched. Here's Why.

NEW YORK -- Federal Reserve Chairwoman Janet Yellen's recent comments calling biotech stock valuations stretched had an immediate, downward effect on stock prices and re-invigorated the long-simmering debate on whether or not the sector was in the midst of a bubble.

Comment?

Related Topix: TheStreetcom, Media, TheStreet, Computers, Financial Markets

Wed Jul 30, 2014

Seeking Alpha

Gilead's Massive Undervaluation: A Pictorial Overview

Despite the rally in the stock the shares are still extremely cheap compared to other large cap biotech concerns as well as against other large cap growth plays.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Startups, CGI Pharmaceuticals, Celgene, Regeneron Pharmaceuticals

Thu Jul 24, 2014

Investor's Business Daily

Celgene, Alexion Beat Estimates, But Biotechs Fall

Big-cap biotechs Celgene and Alexion Pharmaceuticals modestly beat Q2 estimates and raised their guidance early Thursday, but their shares tumbled as Wall Street seemed to turn against the sector.

Comment?

Related Topix: Biotech, Celgene, Medicine, Healthcare Industry, Alexion Pharmaceuticals, Taligen Therapeutics

Seeking Alpha

Celgene's (CELG) CEO, Robert Hugin on Q2 2014 Results - Earnings Call Transcript

Good morning and welcome to the Celgene Second Quarter 2014 Earnings conference call.

Comment?

Related Topix: Biotech, Celgene, Medicine, Healthcare Industry, Oncology, Hematology

Seeking Alpha

Why Gilead Is A Better Buy Than This Rival

We pitch two companies from the biotechnology sector, Gilead and Celgene, against one another in the latest installment of our Head-To-Head series.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Celgene, HIV/AIDS

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••